Suchergebnisse - "Nie, Jingmin"

PubPharm (25)

1

Benefits of switching to a fixed-dose single-tablet elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide co-formulation from free multi- tablet antiretroviral regimens in people living with HIV: A real-world study

enthalten in: ResearchSquare.com | 2023

von Nie, J. | Cao, Q. | Du, X. | +3

2

Risk Factors for CSF/Plasma HIV-1 RNA Discordance in HIV-Infected Patients

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Nie, J. | Zeng, Y. | Zeng, Q. | +2

3

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis : A Prospective Multicenter Cohort Study in China

enthalten in: Infectious diseases and therapy | 2022

von Zhou, Y. | Qin, Y. | Lu, Y. | +14

4

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China

enthalten in: Infectious diseases and therapy | 2022

von Zhou, Y. | Qin, Y. | Lu, Y. | +14

5

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China

enthalten in: Infectious diseases and therapy | 2022

von Zhou, Y. | Qin, Y. | Lu, Y. | +14

6

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China

enthalten in: Infectious diseases and therapy | 2022

von Zhou, Y. | Qin, Y. | Lu, Y. | +14

7

Distribution of nontuberculous mycobacteria in patients with and without HIV/AIDS in Chongqing

enthalten in: HIV medicine | 2022

von Nie, J. | Deng, X. | Zeng, Q. | +3

8

HIV-associated talaromycosis : Does timing of antiretroviral therapy matter?

enthalten in: The Journal of infection | 2022

von Qin, Y. | Zhou, Y. | Liu, S. | +17

9

No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia : Results of an Observational Multicenter Cohort Study

enthalten in: Infectious diseases and therapy | 2022

von Huang, Y. | He, X. | Chen, H. | +15

10

No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study

enthalten in: Infectious diseases and therapy | 2022

von Huang, Y. | He, X. | Chen, H. | +15